Merck KGaA To Use Valo’s AI Tech, Real-World Data In Parkinson’s R&D

 
• By Joseph Haas
  
Merck KGaA will look into Parkinson's therapy with Valo Health
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business